Highlights and Quick Summary
- Annual 10Y Revenue Growth (CAGR) for 2022 was -9.63% (a 15.05% increase from previous year)
- Annual 10Y Revenue Growth (CAGR) for 2021 was -8.37% (a 1643.75% increase from previous year)
- Annual 10Y Revenue Growth (CAGR) for 2020 was -0.48% (a -292.0% decrease from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 10Y Revenue Growth (CAGR) of DURECT Corporation
Most recent 10Y Revenue Growth (CAGR)of DRRX including historical data for past 10 years.Interactive Chart of 10Y Revenue Growth (CAGR) of DURECT Corporation
DURECT Corporation 10Y Revenue Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -9.63% |
| 2021 | – | – | – | – | -8.37% |
| 2020 | – | – | – | – | -0.48% |
| 2019 | – | – | – | – | 0.25% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic